.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Covington
Colorcon
Cantor Fitzgerald
McKesson
Accenture
US Army
Medtronic
Express Scripts

Generated: June 22, 2017

DrugPatentWatch Database Preview

ATROVENT Drug Profile

« Back to Dashboard

What is the patent landscape for Atrovent, and what generic Atrovent alternatives are available?

Atrovent is a drug marketed by Boehringer Ingelheim and is included in five NDAs. There are three patents protecting this drug.

The generic ingredient in ATROVENT is ipratropium bromide. There are seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

Summary for Tradename: ATROVENT

Patents:0
Applicants:1
NDAs:5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list24
Clinical Trials: see list37
Patent Applications: see list5,225
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATROVENT at DailyMed

Pharmacology for Tradename: ATROVENT

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SOLUTION;INHALATION020228-001Sep 29, 1993DISCNYesNo► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT HFA
ipratropium bromide
AEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes8,474,447► SubscribeY ► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020394-001Oct 20, 1995ABRXYesYes► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
AEROSOL, METERED;INHALATION019085-001Dec 29, 1986DISCNNoNo► Subscribe► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 1995ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ATROVENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ATROVENT
ipratropium bromide
AEROSOL, METERED;INHALATION019085-001Dec 29, 19863,681,500► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020394-001Oct 20, 19954,385,048► Subscribe
Boehringer Ingelheim
ATROVENT
ipratropium bromide
SPRAY, METERED;NASAL020393-001Oct 20, 19954,385,048► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
McKesson
Mallinckrodt
Medtronic
Moodys
Julphar
Boehringer Ingelheim
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot